StonvexLoading…
StonvexStonvexStonvexCore line items from AVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $570.00M | $1.96B | $1.43B | $1.03B |
Operating Income | $134.00M | $354.00M | $242.00M | $182.00M |
Net Income | $92.00M | $193.00M | $122.00M | $93.00M |
EPS (Diluted) | $1.11 | $2.38 | $1.51 | $1.15 |
Total Assets | $8.41B | $8.36B | $8.16B | $8.06B |
Total Liabilities | $5.63B | $5.65B | $5.52B | $5.42B |
Cash & Equivalents | $18.00M | $19.00M | $44.00M | $9.00M |
Free Cash Flow OCF − CapEx | $29.00M | $-101.00M | $15.00M | $-22.00M |
Shares Outstanding | 82.64M | 82.19M | 81.37M | 81.11M |